Chris Barton, LCSW, of Horizon Blue Cross Blue Shield of New Jersey, explores how the Youth Behavioral Health Strategy program focuses on addressing the specific needs of youth with mental health and substance use issues through a comprehensive approach.
In this episode of the Managed Care Cast podcast series Frameworks for Advancing Health Equity, Chris Barton, LCSW, the senior director of Integrated Systems of Care & Network Innovation at Horizon Blue Cross Blue Shield of New Jersey, discusses the Youth Behavioral Health Strategy program at Horizon.
The program focuses on addressing the specific needs of youth with mental health and substance use issues through a comprehensive approach structured around 5 key pillars: prevention, early identification and intervention, whole child care, parent and support systems, and community engagement. Launched in response to the escalating youth mental health crisis, exacerbated by factors like social isolation, the program has been operational for 2 years, emphasizing both community-based and virtual resources tailored to meet the needs of youth and their supporting family members.
This includes intensive outpatient treatments, cognitive behavioral therapy, and virtual platforms like MindCare to enhance accessibility, especially for underserved populations. Horizon's initiative aims to not only mitigate immediate mental health challenges but also foster long-term support and resilience among youth and their families.
Trans and Gender Diverse Health Care
Listen above or on one of these podcast services:
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More